Best UK mortgage deals of the week

Average two-year mortgage deal is now around 6%

bioAffinity Technologies, Inc. (BIAF)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.9000

-0.0600

(-3.06%)

At close: 04:00PM EDT

1.8600

-0.04

(-2.11%)

After hours:

04:33PM EDT

Loading interactive chart…

Business Wire
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
SAN ANTONIO, June 12, 2024--bioAffinity Technologies reports a 139% growth in the number of pulmonology practices and physicians ordering CyPath Lung for their patients.
Business Wire
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
SAN ANTONIO, May 15, 2024--bioAffinity Technology reports record Q1 2024 revenue driven by accelerating sales of lung cancer diagnostic CyPath Lung.
Business Wire
bioAffinity Technologies News Update
SAN ANTONIO, May 02, 2024--bioAffinity reports ramp in sales of CyPath® Lung, expanded sales team, new Patient Coach and upcoming presentation at American Thoracic Society.